Placental Findings in Preterm and Term Preeclampsia: An Integrative Review of the Literature

Abstract

Introduction Preeclampsia (PE) is a pregnancy complication associated with increased maternal and perinatal morbidity and mortality. The disease presents with recent onset hypertension (after 20 weeks of gestation) and proteinuria, and can progress to multiple organ dysfunction, with worse outcomes among early onset preeclampsia (EOP) cases (< 34 weeks). The placenta is considered the root cause of PE; it represents the interface between the mother and the fetus, and acts as a macromembrane between the two circulations, due to its villous and vascular structures. Therefore, in pathological conditions, macroscopic and microscopic evaluation can provide clinically useful information that can confirm diagnosis and enlighten about outcomes and future therapeutic benefit.

Objective To perform an integrative review of the literature on pathological placental findings associated to preeclampsia (comparing EOP and late onset preeclampsia [LOP]) and its impacts on clinical manifestations.

Results: Cases of EOP presented worse maternal and perinatal outcomes, and pathophysiological and anatomopathological findings were different between EOP and LOP placentas, with less placental perfusion, greater placental pathological changes with less villous volume (villous hypoplasia), greater amount of trophoblastic debris, syncytial nodules, microcalcification, villous infarcts, decidual arteriolopathy in EOP placentas when compared with LOP placentas. Clinically, the use of low doses of aspirin has been shown to be effective in preventing PE, as well as magnesium sulfate in preventing seizures in cases of severe features.

Conclusion The anatomopathological characteristics between EOP and LOP are significantly different, with large morphological changes in cases of EOP, such as hypoxia, villous infarctions, and hypoplasia, among others, most likely as an attempt to ascertain adequate blood flow to the fetus. Therefore, a better understanding of the basic macroscopic examination and histological patterns of the injury is important to help justify outcomes and to determine cases more prone to recurrence and long-term consequences.

Resumo

Introdução A pré-eclâmpsia (PE) é uma complicação da gravidez associada ao aumento da morbidade e mortalidade materna e perinatal. A doença se apresenta com hipertensão de início recente (após 20 semanas de gestação) e proteinúria, que pode progredir para disfunção de múltiplos órgãos, com resultados piores entre os casos de início precoce (<34 semanas). A placenta é considerada a principal causa da PE, representando a interface entre a mãe e o feto, e atuando como uma macromembrana entre as duas circulações, devido às suas estruturas vilosas e vasculares, de modo que, em condições patológicas, avaliações macroscópicas e microscópicas podem fornecer informações clinicamente úteis, que podem fornecer diagnóstico, prognóstico e benefício terapêutico.

Objetivo Realizar uma revisão integrativa da literatura para compreender e descrever os achados placentários patológicos associados à pré-eclâmpsia e seus impactos nas manifestações clínicas.

Resultados Os casos de início precoce apresentaram piores desfechos maternos e perinatais, e os achados fisiopatológicos e anatomopatológicos foram diferentes entre as placentas de início precoce e início tardio, com menor perfusão placentária, maiores alterações patológicas placentárias com menor volume viloso (hipoplasia vilosa), maior quantidade de debris trofoblásticos, nódulos sinciciais, microcalcificação, infartos vilosos, arteriolopatia decidual em placentas de início precoce quando comparadas com placentas de início tardio. Clinicamente, o uso de baixas doses de aspirina tem se mostrado significativo na prevenção da PE, assim como o sulfato de magnésio na prevenção de convulsões na doença com manifestações de gravidade.

Conclusão As características anatomopatológicas entre a pré-eclâmpsia precoce e tardia são significativamente diferentes, com grandes alterações morfológicas nos casos de início precoce, como hipóxia, infartos vilosos e hipoplasia, entre outros, na tentativa de estabilizar o fluxo sanguíneo para o feto. Portanto, um entendimento comum do exame macroscópico básico e dos padrões histológicos da lesão é importante para maximizar o benefício diagnóstico, prognóstico e terapêutico do exame da placenta e, consequentemente, reduzir os riscos para a mãe e o feto.

Keywords

placenta - maternal mortality and morbidity - preeclampsia early onset - preeclampsia late onset - anatomopathological characteristics

Palavras-chave

placenta - mortalidade e morbidade materna - início precoce da pré-eclâmpsia - início tardio da pré-eclâmpsia - características anatomopatológicas

Publikationsverlauf

Eingereicht: 09. November 2020

Angenommen: 18. Februar 2021

Artikel online veröffentlicht:
30. August 2021

• references

• 1 Malachias MVB, Souza WKSB, Plavnik FL. et al. 7ª Diretriz Brasileira de Hipertensão Arterial. Arq Bras Cardiol 2016; 107 (03, Suppl 3): 1-104 DOI: 10.5935/abc.20160140.
• 2 Hutcheon JA, Lisonkova S, Joseph KS. Epidemiology of pre-eclampsia and the other hypertensive disorders of pregnancy. Best Pract Res Clin Obstet Gynaecol 2011; 25 (04) 391-403 DOI: 10.1016/j.bpobgyn.2011.01.006.
• 3 Mayrink J, Souza RT, Feitosa FE, Rocha Filho EA, Leite DF, Vettorazzi J. et al; Preterm SAMBA study group. Incidence and risk factors for Preeclampsia in a cohort of healthy nulliparous pregnant women: a nested case-control study. Sci Rep 2019; 9 (01) 9517 DOI: 10.1038/s41598-019-46011-3.
• 4 Bernardes TP, Mol BW, Ravelli ACJ, van den Berg P, Boezen HM, Groen H. Early and late onset pre-eclampsia and small for gestational age risk in subsequent pregnancies. PLoS One 2020; 15 (03) e0230483 DOI: 10.1371/journal.pone.0230483.
• 5 Giordano JC, Parpinelli MA, Cecatti JG, Haddad SM, Costa ML, Surita FG. et al. The burden of eclampsia: results from a multicenter study on surveillance of severe maternal morbidity in Brazil. PLoS One 2014; 9 (05) e97401 DOI: 10.1371/journal.pone.0097401.
• 6 Peraçoli JC, Borges VTM, Ramos JGL, Cavalli RC, Costa SHAM, Oliveira LG. et al. Pre-eclampsia/Eclampsia. Rev Bras Ginecol Obstet 2019; 41 (05) 318-332 DOI: 10.1055/s-0039-1687859.
• 7 Pascoal ACF, Katz L, Pinto MH, Santos CA, Braga LCO, Maia SB. et al. Serum magnesium levels during magnesium sulfate infusion at 1 gram/hour versus 2 grams/hour as a maintenance dose to prevent eclampsia in women with severe preeclampsia: A randomized clinical trial. Medicine (Baltimore) 2019; 98 (32) e16779 DOI: 10.1097/MD.0000000000016779.
• 8 Burton GJ, Redman CW, Roberts JM, Moffett A. Pre-eclampsia: pathophysiology and clinical implications. BMJ 2019; 366: l2381 DOI: 10.1136/bmj.l2381.
• 9 Gestational Hypertension and Preeclampsia. Gestational Hypertension and Preeclampsia: ACOG Practice Bulletin, Number 222. Obstet Gynecol 2020; 135 (06) e237-e260 DOI: 10.1097/AOG.0000000000003891.
• 10 Brown MA, Magee LA, Kenny LC, Karumanchi SA, McCarthy FP, Saito S. et al; International Society for the Study of Hypertension in Pregnancy (ISSHP). The hypertensive disorders of pregnancy: ISSHP classification, diagnosis & management recommendations for international practice. Pregnancy Hypertens 2018; 13: 291-310 DOI: 10.1016/j.preghy.2018.05.004.
• 11 Brown MA, Magee LA, Kenny LC, Karumanchi SA, McCarthy FP, Saito S. et al; International Society for the Study of Hypertension in Pregnancy (ISSHP). Hypertensive disorders of pregnancy: ISSHP classification, diagnosis, and management recommendations for international practice. Hypertension 2018; 72 (01) 24-43 DOI: 10.1161/HYPERTENSIONAHA.117.10803.
• 12 ACOG Practice Bulletin No. 202: Gestational Hypertension and Preeclampsia. Obstet Gynecol 2019; 133 (01) 1 DOI: 10.1097/AOG.0000000000003018.
• 13 Khan N, Andrade W, De Castro H, Wright A, Wright D, Nicolaides KH. Impact of new definitions of pre-eclampsia on incidence and performance of first-trimester screening. Ultrasound Obstet Gynecol 2020; 55 (01) 50-57 DOI: 10.1002/uog.21867.
• 14 Rezende GP, Casagrande L, Guida JPS, Parpinelli MA, Surita FG, Costa ML. Maternal and perinatal outcomes of pregnancies complicated by chronic hypertension followed at a referral hospital. Rev Bras Ginecol Obstet 2020; 42 (05) 248-254 DOI: 10.1055/s-0040-1709190.
• 15 Rayburn WF. The placenta: its importance from womb to tomb. Obstet Gynecol Clin North Am 2020; 47 (01) xiii-xiv DOI: 10.1016/j.ogc.2020.01.002.
• 16 Redman CW, Sargent IL, Staff AC. IFPA Senior Award Lecture: making sense of pre-eclampsia - two placental causes of preeclampsia?. Placenta 2014; 35 (Suppl): S20-S25 DOI: 10.1016/j.placenta.2013.12.008.
• 17 Pijnenborg R, Vercruysse L, Hanssens M. The uterine spiral arteries in human pregnancy: facts and controversies. Placenta 2006; 27 (9-10): 939-958 DOI: 10.1016/j.placenta.2005.12.006.
• 18 Ravishankar S, Redline RW. What obstetricians need to know about placental pathology. Obstet Gynecol Clin North Am 2020; 47 (01) 29-48 DOI: 10.1016/j.ogc.2019.10.007.
• 19 Kaufmann P, Black S, Huppertz B. Endovascular trophoblast invasion: implications for the pathogenesis of intrauterine growth retardation and preeclampsia. Biol Reprod 2003; 69 (01) 1-7 DOI: 10.1095/biolreprod.102.014977.
• 20 Burton GJ, Jauniaux E. What is the placenta?. Am J Obstet Gynecol 2015; 213 (4, Suppl): 6.e1-S6–S8 DOI: 10.1016/j.ajog.2015.07.050.
• 21 Burton GJ. Stimulation of early placental development through a trophoblast-endometrial Dialogue. J Equine Vet Sci 2018; 66: 14-18 DOI: 10.1016/j.jevs.2018.03.003.
• 22 Hay E, Lucariello A, Contieri M, Trucillo M, Pavese L, Guerra G. et al. Differential expression of several factors involved in placental development in normal and abnormal condition. Placenta 2020; 95: 1-8 DOI: 10.1016/j.placenta.2020.04.006.
• 23 Benirschke K, Kaufmann P. Architecture of normal villous tree. In: Benirschke K, Kaufmann P. Pathology human placenta. 4th ed.. New York: Springer; 2000: 116-54
• 24 Chaddha V, Viero S, Huppertz B, Kingdom J. Developmental biology of the placenta and the origins of placental insufficiency. Semin Fetal Neonatal Med 2004; 9 (05) 357-369 DOI: 10.1016/j.siny.2004.03.006.
• 25 Conrad KP, Rabaglino MB, Post Uiterweer ED. Emerging role for dysregulated decidualization in the genesis of preeclampsia. Placenta 2017; 60: 119-129 DOI: 10.1016/j.placenta.2017.06.005.
• 26 Garrido-Gomez T, Dominguez F, Quiñonero A, Diaz-Gimeno P, Kapidzic M, Gormley M. et al. Defective decidualization during and after severe preeclampsia reveals a possible maternal contribution to the etiology. Proc Natl Acad Sci U S A 2017; 114 (40) E8468-E8477 DOI: 10.1073/pnas.1706546114.
• 27 Okae H, Toh H, Sato T, Hiura H, Takahashi S, Shirane K. et al. Derivation of human trophoblast stem cells. Cell Stem Cell 2018; 22 (01) 50-63.e6 DOI: 10.1016/j.stem.2017.11.004.
• 28 Tannetta D, Masliukaite I, Vatish M, Redman C, Sargent I. Update of syncytiotrophoblast derived extracellular vesicles in normal pregnancy and preeclampsia. J Reprod Immunol 2017; 119: 98-106 DOI: 10.1016/j.jri.2016.08.008.
• 29 Roberts VHJ, Morgan TK, Bednarek P, Morita M, Burton GJ, Lo JO. et al. Early first trimester uteroplacental flow and the progressive disintegration of spiral artery plugs: new insights from contrast-enhanced ultrasound and tissue histopathology. Hum Reprod 2017; 32 (12) 2382-2393 DOI: 10.1093/humrep/dex301.
• 30 El-Sayed AAF. Preeclampsia: A review of the pathogenesis and possible management strategies based on its pathophysiological derangements. Taiwan J Obstet Gynecol 2017; 56 (05) 593-598 DOI: 10.1016/j.tjog.2017.08.004.
• 31 Aouache R, Biquard L, Vaiman D, Miralles F. Oxidative stress in preeclampsia and placental diseases. Int J Mol Sci 2018; 19 (05) 1496 DOI: 10.3390/ijms19051496.
• 32 Lyall F, Robson SC, Bulmer JN. Spiral artery remodeling and trophoblast invasion in preeclampsia and fetal growth restriction: relationship to clinical outcome. Hypertension 2013; 62 (06) 1046-1054 DOI: 10.1161/HYPERTENSIONAHA.113.01892.
• 33 Staff AC, Johnsen GM, Dechend R, Redman CWG. Preeclampsia and uteroplacental acute atherosis: immune and inflammatory factors. J Reprod Immunol 2014; 101-102: 120-126 DOI: 10.1016/j.jri.2013.09.001.
• 34 Staff AC, Dechend R, Pijnenborg R. Learning from the placenta: acute atherosis and vascular remodeling in preeclampsia-novel aspects for atherosclerosis and future cardiovascular health. Hypertension 2010; 56 (06) 1026-1034 DOI: 10.1161/HYPERTENSIONAHA.110.157743.
• 35 Redman CW, Sargent IL. Placental stress and pre-eclampsia: a revised view. Placenta 2009; 30 (Suppl A ): S38-S42 DOI: 10.1016/j.placenta.2008.11.021.
• 36 Burton GJ, Woods AW, Jauniaux E, Kingdom JC. Rheological and physiological consequences of conversion of the maternal spiral arteries for uteroplacental blood flow during human pregnancy. Placenta 2009; 30 (06) 473-482 DOI: 10.1016/j.placenta.2009.02.009.
• 37 Sohlberg S, Mulic-Lutvica A, Lindgren P, Ortiz-Nieto F, Wikström AK, Wikström J. Placental perfusion in normal pregnancy and early and late preeclampsia: a magnetic resonance imaging study. Placenta 2014; 35 (03) 202-206 DOI: 10.1016/j.placenta.2014.01.008.
• 38 Sebire NJ. Implications of placental pathology for disease mechanisms; methods, issues and future approaches. Placenta 2017; 52: 122-126 DOI: 10.1016/j.placenta.2016.05.006.
• 39 Jones CJP, Fox H. An ultrastructural and ultrahistochemical study of the human placenta in maternal pre-eclampsia. Placenta 1980; 1 (01) 61-76 DOI: 10.1016/s0143-4004(80)80016-6.
• 40 Holland O, Dekker Nitert M, Gallo LA, Vejzovic M, Fisher JJ, Perkins AV. Review: Placental mitochondrial function and structure in gestational disorders. Placenta 2017; 54: 2-9 DOI: 10.1016/j.placenta.2016.12.012.
• 41 Longtine MS, Chen B, Odibo AO, Zhong Y, Nelson DM. Villous trophoblast apoptosis is elevated and restricted to cytotrophoblasts in pregnancies complicated by preeclampsia, IUGR, or preeclampsia with IUGR. Placenta 2012; 33 (05) 352-359 DOI: 10.1016/j.placenta.2012.01.017.
• 42 Yung HW, Atkinson D, Campion-Smith T, Olovsson M, Charnock-Jones DS, Burton GJ. Differential activation of placental unfolded protein response pathways implies heterogeneity in causation of early- and late-onset pre-eclampsia. J Pathol 2014; 234 (02) 262-276 DOI: 10.1002/path.4394.
• 43 Khong TY, Mooney EE, Ariel I, Balmus NCM, Boyd TK, Brundler M-A. et al. Sampling and definitions of placental lesions: Amsterdam placental working group consensus statement. Arch Pathol Lab Med 2016; 140 (07) 698-713 DOI: 10.5858/arpa.2015-0225-CC.
• 44 Turowski G, Tony Parks W, Arbuckle S, Jacobsen AF, Heazell A. The structure and utility of the placental pathology report. APMIS 2018; 126 (07) 638-646 DOI: 10.1111/apm.12842.
• 45 Redline RW. Maternal vascular malperfusion. In: Redline RW, Boyd TK, Roberts DJ. editors. Placental and gestational pathology. Cambridge: Cambridge University Press; 2018: 62-9
• 46 Redline RW. Maternal vascular/trophoblastic developmental abnormalities. In: Redline RW, Boyd TK, Roberts DJ. editors. Placental and gestational pathology. Cambridge: Cambridge University Press; 2018: 49-57
• 47 Shchegolev AI, Lyapin VM, Tumanova UN, Vodneva DN, Shmakov RG. [Histological hanges in the placenta and vascularization of its villi in early- and late-onset preeclampsia]. Arkh Patol 2016; 78 (01) 13-18 DOI: 10.17116/patol201678113-18.
• 48 Orabona R, Donzelli CM, Falchetti M, Santoro A, Valcamonico A, Frusca T. Placental histological patterns and uterine artery Doppler velocimetry in pregnancies complicated by early or late pre-eclampsia. Ultrasound Obstet Gynecol 2016; 47 (05) 580-585 DOI: 10.1002/uog.15799.
• 49 Khodzhaeva ZS, Kogan YA, Shmakov RG, Klimenchenko NI, Akatyeva AS, Vavina OV. et al. Clinical and pathogenetic features of early- and late-onset pre-eclampsia. J Matern Fetal Neonatal Med 2016; 29 (18) 2980-2986 DOI: 10.3109/14767058.2015.1111332.
• 50 Zhang X, Jia H, Wang Y, Xie J, Gu Y. [Early and late onset severe preeclampsia: a clinicopathologic study of 178 placentas]. Zhonghua Bing Li Xue Za Zhi 2015; 44 (12) 879-883
• 51 Kovo M, Schreiber L, Ben-Haroush A, Gold E, Golan A, Bar J. The placental component in early-onset and late-onset preeclampsia in relation to fetal growth restriction. Prenat Diagn 2012; 32 (07) 632-637 DOI: 10.1002/pd.3872.
• 52 Ogge G, Chaiworapongsa T, Romero R, Hussein Y, Kusanovic JP, Yeo L. et al. Placental lesions associated with maternal underperfusion are more frequent in early-onset than in late-onset preeclampsia. J Perinat Med 2011; 39 (06) 641-652 DOI: 10.1515/jpm.2011.098.
• 53 van der Merwe JL, Hall DR, Wright C, Schubert P, Grové D. Are early and late preeclampsia distinct subclasses of the disease--what does the placenta reveal?. Hypertens Pregnancy 2010; 29 (04) 457-467 DOI: 10.3109/10641950903572282.
• 54 Egbor M, Ansari T, Morris N, Green CJ, Sibbons PD. Morphometric placental villous and vascular abnormalities in early- and late-onset pre-eclampsia with and without fetal growth restriction. BJOG 2006; 113 (05) 580-589 DOI: 10.1111/j.1471-0528.2006.00882.x.
• 55 Mittal N, Byard RW, Dahlstrom JE. A practical guide to placental examination for forensic pathologists. Forensic Sci Med Pathol 2020; 16 (02) 295-312 DOI: 10.1007/s12024-019-00214-2.
• 56 Roberge S, Bujold E, Nicolaides KH. Aspirin for the prevention of preterm and term preeclampsia: systematic review and metaanalysis. Am J Obstet Gynecol 2018; 218 (03) 287-293.e1 DOI: 10.1016/j.ajog.2017.11.561.
• 57 Berhan Y, Berhan A. Should magnesium sulfate be administered to women with mild pre-eclampsia? A systematic review of published reports on eclampsia. J Obstet Gynaecol Res 2015; 41 (06) 831-842 DOI: 10.1111/jog.12697.
• 58 Barbosa FT, Barbosa LT, Jucá MJ, Cunha RM. Applications of magnesium sulfate in obstetrics and anesthesia. Rev Bras Anestesiol 2010; 60 (01) 104-110 DOI: 10.1016/s0034-7094(10)70013-1.